why choose us

First received: July 14, 2023

Clinical Trial: Open-Label Extension Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Uncontrolled Hypertension

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hypertension

Study Type: INTERVENTIONAL


Official Title: An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Uncontrolled Hypertension

Brief Summary: This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled hypertension.

Read more